![Joseph J. Elliot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph J. Elliot
Plus aucun poste en cours
Profil
Joseph J.
Elliot formerly worked at LymphoSign, Inc., as President & Chief Executive Officer, Receptor Therapeutics, Inc., as President, Chief Executive Officer & Director, Cytochroma, Inc., as Chairman & President, Targanta Therapeutics, Inc., as Chairman & President, Nexia Biotechnologies, Inc., as Director, BioStar, Inc., as Director, MDS Proteomics, Inc., as Vice President & General Manager, Lumira Capital Investment Management, Inc., as Vice President in 1999, Pharmacia Canada, Inc., as Principal, Exogen Neurosciences, Inc., as Chief Operating Officer, MDS Ocata, Inc., as Vice President & General Manager-Operations in 2012, and Sanofi-Aventis Canada, Inc., as Principal.
Dr. Elliot received his doctorate degree in 1980 from McMaster University.
Anciens postes connus de Joseph J. Elliot
| Sociétés | Poste | Fin |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Corporate Officer/Principal | 01/01/1999 |
Sanofi-Aventis Canada, Inc.
 Sanofi-Aventis Canada, Inc. Pharmaceuticals: MajorHealth Technology Provides and develops medicines | Corporate Officer/Principal | - |
Pharmacia Canada, Inc. | Corporate Officer/Principal | - |
MDS Ocata, Inc. | Directeur des opérations | - |
Exogen Neurosciences, Inc. | Directeur des opérations | - |
Formation de Joseph J. Elliot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Nexia Biotechnologies, Inc.
 Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Produces therapeutic proteins and other biomaterials for the treatment of serious diseases | Health Technology |
MDS Proteomics, Inc.
 MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Commercial Services |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription products for the prevention of vitamin D insufficiency | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
BioStar, Inc.
 BioStar, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets point-of-care immunoassay test kits | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotic drugs and other related products | Health Technology |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Receptor Therapeutics, Inc.
 Receptor Therapeutics, Inc. BiotechnologyHealth Technology Develops anti-cancer therapies | Health Technology |
Pharmacia Canada, Inc. | |
Exogen Neurosciences, Inc. | |
MDS Ocata, Inc. | |
Sanofi-Aventis Canada, Inc.
Sanofi-Aventis Canada, Inc. Pharmaceuticals: MajorHealth Technology Provides and develops medicines | Health Technology |
Choisissez Zonebourse 
